DNA Mutations

Core Idea

A mutation is any heritable change in the DNA sequence. Point mutations include transitions (purine↔purine or pyrimidine↔pyrimidine) and transversions (purine↔pyrimidine). At the protein level, a point mutation can be silent (same amino acid due to degeneracy), missense (different amino acid), or nonsense (premature stop codon). Insertions or deletions of bases that are not multiples of three cause frameshifts, which alter every downstream codon and typically produce a nonfunctional protein. Chromosomal mutations (deletions, duplications, inversions, translocations) affect larger stretches of the genome.

How It's Best Learned

Use a codon table to classify point mutations as silent, missense, or nonsense. Introduce a one-base insertion into a sample coding sequence and observe the frameshift effect on the translated protein.

Common Misconceptions

• 'Mutation' is not inherently harmful; many are silent or neutral, and some are beneficial.
• Frameshift mutations from a single indel are generally more damaging than point mutations because they disrupt all downstream codons.

Explainer

DNA is a remarkably stable molecule, but not a perfect one. Every time a cell divides, its entire genome is copied, and replication errors occur at a low rate. When changes to the DNA sequence survive proofreading and repair mechanisms and are passed on to daughter cells, they are called mutations. Understanding mutation types is essential because the relationship between a DNA change and its phenotypic consequence depends entirely on *where* and *how* the sequence changes.

Building on your knowledge of the genetic code, consider what happens when a single base is substituted in a coding sequence (a point mutation). If the new codon specifies the same amino acid — possible because the code is degenerate, with multiple codons per amino acid — the mutation is *silent*. If it specifies a different amino acid, it is a *missense* mutation; the protein may or may not function normally depending on the chemical nature of the substitution and its location within the protein structure. If the new codon is a stop codon (UAA, UAG, or UGA), it is a *nonsense* mutation that truncates the protein, usually producing a nonfunctional product. The distinction between transitions (purine↔purine or pyrimidine↔pyrimidine) and transversions (purine↔pyrimidine) matters because transitions are more chemically common and are less likely to drastically change codon meaning.

Insertions and deletions (collectively called *indels*) have consequences that depend on their size relative to the codon length of three. If the number of inserted or deleted bases is a multiple of three, the reading frame is preserved downstream of the change — only the codons at the indel site are directly disrupted, and the rest of the protein is produced normally. But if even a single base is inserted or deleted, every codon downstream of that position is read in a new frame. This *frameshift* typically generates a completely different (and usually nonfunctional) amino acid sequence and introduces a premature stop codon. This is why frameshifts are generally far more destructive than point mutations: they corrupt the entire downstream blueprint.

A critical intuition to resist: mutations are not inherently harmful. Most of the human genome does not encode proteins, so mutations in non-coding regions often have no phenotypic effect. Among coding mutations, silent mutations have no protein-level consequence by definition. And many missense mutations are tolerable if the substituted amino acid is chemically similar to the original or is located outside the protein's functional domains. The vast majority of mutations in any individual's genome are neutral. Harmful mutations tend to be eliminated from populations by natural selection; rare beneficial mutations are the raw material of adaptive evolution.

Finally, the cellular context of a mutation matters. Mutations in *somatic* (body) cells affect only the individual carrying them and are not passed to offspring — they can contribute to cancer if they disrupt cell cycle control, but they die with the organism. Only mutations in *germline* cells (eggs and sperm) are heritable. Understanding this distinction clarifies why cancer is not typically inherited in the same way as single-gene genetic diseases, and why germline mutation rates are under particularly intense evolutionary pressure to remain low.